Increased 17β-hydroxysteroid dehydrogenase type 1 levels in primary cervical cancer

被引:7
|
作者
Tomaszewska, Agata [1 ,2 ]
Roszak, Andrzej [3 ,4 ]
Pawlik, Piotr [5 ]
Sajdak, Stefan [5 ]
Jagodzinski, Pawel Piotr [1 ]
机构
[1] Poznan Univ Med Sci, Dept Biochem & Mol Biol, PL-60781 Poznan, Poland
[2] Poznan Univ Med Sci, Ctr Orthodont Miniimplants, Chair & Clin Maxillofacial Orthoped & Orthodont, PL-60781 Poznan, Poland
[3] Poznan Univ Med Sci, Dept Electroradiol, PL-60781 Poznan, Poland
[4] Greater Poland Canc Ctr, Dept Radiotherapy & Gynecol Oncol, Poznan, Poland
[5] Poznan Univ Med Sci, Div Gynecol Surg, PL-60781 Poznan, Poland
关键词
HSD17B1; Cervical cancer; 17; beta-Estradiol; HUMAN-PAPILLOMAVIRUS TYPE-16; CELL-LINES; SQUAMOUS CARCINOGENESIS; ESTROGEN; EXPRESSION; ESTRADIOL; RISK; E6; 17-BETA-ESTRADIOL; DEHYDROGENASES;
D O I
10.1016/j.biopha.2015.04.018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Infections with oncogenic human papillomavirus (HPV) strains are recognized as the major risk factor for developing malignant lesions in the uterine cervix. However, several findings have demonstrated cooperation between HPV infection and 17 beta-estradiol (E2) in cervical carcinogenesis. The 17 beta-hydroxysteroid dehydrogenase type 1 (HSD17B1) is the enzyme involved in the transformation of estrone (E1) into E2. In this study, we identified the HSD17B1 transcript and protein in HeLa, SiHa, Ca Ski and C-33A cervical cancer cells. These cells were able to convert E1 to E2 in a time-dependent manner. Moreover, we identified the HSD17B1 transcript and protein in primary cancerous tissues (n = 28) and in histologically unchanged tissues (n = 25). We did not observe significant differences (P = 0.33) between the HSD17B1 transcript levels in cancerous tissues and histologically unchanged tissues. However, we found an overrepresentation of the HSD17B1 protein in cancerous tissues compared with histologically unchanged tissues (P < 0.001). This overrepresentation of the HSD17B1 protein in primary cervical cancerous tissues may be responsible for the local conversion of E1 to E2. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:179 / 183
页数:5
相关论文
共 50 条
  • [1] High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer
    Cornel, Karlijn M. C.
    Krakstad, Camilla
    Delvoux, Bert
    Xanthoulea, Sofia
    Jori, Balazs
    Bongers, Marlies Y.
    Konings, Gonda F. J.
    Kooreman, Loes F. S.
    Kruitwagen, Roy F. P. M.
    Salvesen, Helga B.
    Romano, Andrea
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2017, 442 (0C) : 51 - 57
  • [2] 17β-hydroxysteroid dehydrogenase type 1 improves survival in serous epithelial ovarian tumors
    Pedernera, Enrique
    Morales-Vasquez, Flavia
    Gomora, Maria J.
    Almaraz, Miguel A.
    Mena, Esteban
    Perez-Montiel, Delia
    Rendon, Elizabeth
    Lopez-Basave, Horacio
    Maldonado-Cubas, Juan
    Mendez, Carmen
    ENDOCRINE CONNECTIONS, 2023, 12 (12)
  • [3] 17β-Hydroxysteroid dehydrogenase type 1 as predictor of tamoxifen response in premenopausal breast cancer
    Kallstrom, Ann-Christine
    Salme, Rebecka
    Ryden, Lisa
    Nordenskjold, Bo
    Jonsson, Per-Ebbe
    Stal, Olle
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (05) : 892 - 900
  • [4] 17β-hydroxysteroid dehydrogenase type Gene 1937 A &gt; G Polymorphism as a Risk Factor for Cervical Cancer Progression in the Polish Population
    Lutkowska, Anna
    Roszak, Andrzej
    Jagodzinski, Pawel P.
    PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (02) : 317 - 322
  • [5] 17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based study
    Collin, Lindsay J.
    Ulrichsen, Sinna P.
    Ahern, Thomas P.
    Goodman, Michael
    McCullough, Lauren E.
    Waller, Lance A.
    Bang Christensen, Kristina
    Damkier, Per
    Hamilton-Dutoit, Stephen
    Lauridsen, Kristina L.
    Yacoub, Rami
    Christiansen, Peer M.
    Ejlertsen, Bent
    Sorensen, Henrik Toft
    Cronin-Fenton, Deirdre P.
    Lash, Timothy L.
    ACTA ONCOLOGICA, 2020, 59 (03) : 329 - 333
  • [6] The design of novel 17β-hydroxysteroid dehydrogenase type 3 inhibitors
    Vicker, Nigel
    Sharland, Christopher M.
    Heaton, Wesley B.
    Gonzalez, Ana M. Ramos
    Bailey, Helen V.
    Smith, Andrew
    Springall, Jeremy S.
    Day, Joanna M.
    Tutill, Helena J.
    Reed, Michael J.
    Purohit, Atul
    Potter, Barry V. L.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 301 (1-2) : 259 - 265
  • [7] Differential estrogenic 17β-hydroxysteroid dehydrogenase activity and type 12 17β-hydroxysteroid dehydrogenase expression levels in preadipocytes and differentiated adipocytes
    Bellemare, Veronique
    Laberge, Philippe
    Noel, Suzanne
    Tchernof, Andre
    Luu-The, Van
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2009, 114 (3-5) : 129 - 134
  • [8] Overexpression of 17β-Hydroxysteroid Dehydrogenase Type 1 Increases the Exposure of Endometrial Cancer to 17β-Estradiol
    Cornel, Karlijn M. C.
    Kruitwagen, Roy F. P. M.
    Delvoux, Bert
    Visconti, Laura
    Van de Vijver, Koen K.
    Day, Joanna M.
    Van Gorp, Toon
    Hermans, Rob J. J.
    Dunselman, Gerard A.
    Romano, Andrea
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (04) : E591 - E601
  • [9] 17Beta-hydroxysteroid dehydrogenase enzymes and breast cancer
    Jansson, Agneta
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2009, 114 (1-2) : 64 - 67
  • [10] Expression of 17β-hydroxysteroid dehydrogenase type 2 is associated with some clinicopathological features in gastric cancer
    Frycz, Bartosz Adam
    Murawa, Dawid
    Borejsza-Wysocki, Maciej
    Marciniak, Ryszard
    Murawa, Pawel
    Drews, Michal
    Jagodzinski, Pawel Piotr
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 70 : 24 - 27